NCT01109940 - Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Ankylosing Spondylitis

Interventions

BIOLOGICAL

AIN457A

Trial Locations (15)

Novartis Investigative Site, Amsterdamn

Novartis Investigative Site, Berlin

Novartis Investigative Site, Duncansville

Novartis Investigative Site, Hamburg

Novartis Investigative Site, Knoxville

Novartis Investigative Site, Jackson

Novartis Investigative Site, Herne

Novartis Investigative Site, Springfield

Novartis Investigative Site, Springfield

Novartis Investigative Site, Oklahoma City

Novartis Investigative Site, Benbrook

Novartis Investigative Site, Paradise Valley

Novartis Investigative Site, Spokane

Novartis Investigative Site, München

Novartis Investigative Site, Newcastle upon Tyne